☆ 4.7 Article

De-escalation of five-year adjuvant endocrine therapy in patients with estrogen receptor-low positive (immunohistochemistry staining 1%-10%) breast cancer: Propensity-matched analysis from a prospectively maintained cohort

CANCER (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient-reported outcomes substudy

Sofia F. Garcia et al.

Summary: The study found that patients with early-stage breast cancer who received adjuvant chemoendocrine therapy reported greater fatigue and endocrine symptoms at early time points, but these differences lessened over time, demonstrating early chemotherapy effects more than long-term ones. Treatment arm differences in endocrine symptoms were more evident in postmenopausal patients.

CANCER (2022)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Review Oncology

Estrogen receptor-low breast cancer: Biology chaos and treatment paradox

Ke-Da Yu et al.

Summary: Hormone receptor testing is crucial for guiding treatment choices in breast cancer patients. The controversy lies in defining ER status and eligibility for treatment, especially regarding ER-low positive tumors. This subgroup may have unique molecular features and different therapeutic responses compared to ER-high positive tumors.

CANCER COMMUNICATIONS (2021)

添加到收藏夹

Article Oncology

Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials

Meredith M. Regan et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

添加到收藏夹

Article Medicine, General & Internal

Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer

Ke-Da Yu et al.

BMC MEDICINE (2015)

添加到收藏夹

Article Oncology

Which threshold for ER positivity? a retrospective study based on 9639 patients

M. Yi et al.

ANNALS OF ONCOLOGY (2014)

添加到收藏夹

Article Oncology

Survival Outcomes in Breast Cancer Patients With Low Estrogen/Progesterone Receptor Expression

Alessandra Balduzzi et al.

CLINICAL BREAST CANCER (2014)

添加到收藏夹

Article Oncology

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Antonio C. Wolff et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

添加到收藏夹

Article Oncology

Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers

Kanwal P. S. Raghav et al.

CANCER (2012)

添加到收藏夹

Article Oncology

Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry

Takayuki Iwamoto et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

添加到收藏夹

Article Oncology

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

M. Elizabeth H. Hammond et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

添加到收藏夹

Article Mathematical & Computational Biology

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples

Peter C. Austin

STATISTICS IN MEDICINE (2009)

添加到收藏夹

Article Health Care Sciences & Services

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

Erik von Elm et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)

添加到收藏夹

Article Oncology

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer:: BIG 1-98

Giuseppe Viale et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)

添加到收藏夹

Article Oncology

Re-evaluating adjuvant breast cancer trials:: Assessing hormone receptor status by immunohistochemical versus extraction assays

Meredith M. Regan et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)

添加到收藏夹

Article Multidisciplinary Sciences

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

T Sorlie et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.